This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

6 Aug 2013

FDA approves new drug for serious childhood arthritis

A new drug to treat systemic juvenile idiopathic arthritis has been given FDA approval


The US Food and Drug Administration (FDA) has approved a once-monthly subcutaneous injection for the treatment of serious childhood arthritis.

Related News